GT Biopharma

GTBP

Capitalización de mercado USD 10.1 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
26	26 Wells Fargo San Francisco, California	USD 7.83 k	-USD 20	-2	-0.3%
27	27 Tempus Wealth Planning Irvine, California	USD 7.35 k	+USD 6.08 k	+600	Nuevas
28	AIS 28 AM Investment Strategies Chattanooga, Tennessee	USD 7 k	–	–	–
29	29 Two Sigma Securities New York	USD 6.56 k	-USD 7.47 k	-737	-58%
30	30 Prospera Financial Services Dallas, Texas	USD 6.12 k	+USD 203	+20	+4%
31	31 Verdence Capital Advisors Hunt Valley, Maryland	USD 5.88 k	–	–	–
32	32 LaSalle St. Investment Advisors Elmhurst, Illinois	USD 5.39 k	–	–	–
33	33 Mayflower Financial Advisors Boston, Massachusetts	USD 5.39 k	+USD 4.46 k	+440	Nuevas
34	34 Parsons Capital Management Providence, Rhode Island	USD 5.34 k	–	–	–
35	35 Koss-Olinger Consulting Gainesville, Florida	USD 4.9 k	+USD 4.06 k	+400	Nuevas
36	36 North Star Asset Management Neenah, Wisconsin	USD 4.9 k	+USD 4.06 k	+400	Nuevas
37	37 BlackRock New York	USD 4.07 k	-USD 41	-4	-1%
38	38 Royal Bank of Canada Toronto, Ontario, Canada	USD 4 k	+USD 3.03 k	+299	+5,980%
39	39 HBK Sorce Advisory Erie, Pennsylvania	USD 3.18 k	–	–	–
40	40 Atlantic Union Bankshares Glen Allen, Virginia	USD 2.62 k	+USD 2.17 k	+214	Nuevas
41	41 Allworth Financial Folsom, California	USD 2.2 k	–	–	–
42	42 Newbridge Financial Services Group Boca Raton, Florida	USD 1.84 k	–	–	–
43	43 Farther Finance Advisors San Francisco, California	USD 1.47 k	–	–	–
44	44 MassMutual Private Wealth & Trust Windsor, Connecticut	USD 1.47 k	–	–	–
45	45 West Financial Advisors Des Moines, Iowa	USD 1.22 k	–	–	–
46	46 Stone House Investment Management Tunkhannock, Pennsylvania	USD 1 k	+USD 324	+32	+64%
47	47 Tower Research Capital (TRC) New York	USD 831	–	–	–
48	48 Triumph Capital Management Denver, Colorado	USD 810	–	–	–
49	49 Barclays London, United Kingdom	USD 706	+USD 588	+58	Nuevas
50	50 Jones Financial Companies Des Peres, Missouri	USD 645	+USD 608	+60	Nuevas

GT Biopharma GTBP Capitalización de mercado USD 10.1 M

GT Biopharma

GTBP

Capitalización de mercado USD 10.1 M